VCYT
Veracyte Inc
41.50$
+4.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +486.9% | +69.8% | +81.5% | |
| – | +91.8% | +55.8% | +9.4% | +2.1% | +5.0% | +93.0% | +146.6% | +32.3% | +4.9% | -13.7% | -8.7% | |
| – | +57.9% | +13.9% | +3.7% | -10.0% | +64.6% | +32.5% | +73.3% | +18.7% | +24.0% | +9.4% | +20.3% | |
| – | +4,127.4% | +19.9% | -3.1% | -11.5% | +66.8% | +59.0% | +69.6% | +4.7% | – | – | – | |
| – | – | -1,265.3% | – | – | – | – | – | -488.3% | – | – | – | |
| – | +204.6% | -31.7% | -58.3% | +6.8% | +47.1% | +2.9% | +89.5% | +59.0% | +16.5% | +13.3% | -14.3% | |
| – | -25.7% | -37.1% | -71.6% | +56.8% | +2,180.3% | -91.0% | +19,165.2% | -96.0% | – | -472.4% | -83.6% | |
| – | -100.0% | – | – | – | – | +293.6% | – | – | – | – | – | |
| – | +0.0% | – | -93.7% | -101.4% | +3,156.7% | +293.6% | +134.8% | -64.9% | +112.9% | – | – | |
| – | – | +1.5% | -104.0% | -62.5% | +8,532.9% | -99.6% | +1,181.0% | +0.0% | -100.0% | – | – | |
| – | +8,554.4% | +38.7% | -100.4% | – | +113.9% | +59.9% | +192.9% | -99.4% | -18.8% | +72.9% | -186.1% | |
| – | – | +394.7% | -225.8% | – | +84.4% | +133.7% | -192.6% | – | – | -62.6% | +430.4% | |
| – | – | – | – | – | – | – | – | – | – | +86.2% | +98.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.